A Michigan company that is developing a psoriasis treatment based on licensed technology developed by UW-Madison Professor Hector DeLuca has filed for an initial public offering of stock.
….DeLuca, chairman of the UW Department of Biochemistry, is the world’s leading expert on the metabolism and mechanism of vitamin D with more than 150 active patents in the U.S. and more than 1,200 patents outside the U.S.